Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 12 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase II/III Combination Chemotherapy with AMSA/ARA-C for Reinduction and AMSA/VP-16 for Maintenance in Children with Relapsed ANLL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 22				NCI				CCG-201


2.		Phase III Reinduction with ARA-C/DNM vs CYC/DNM and Maintenance with ARA-C/CTX vs CYC/CTX for Acute Nonlymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 20				NCI				CCG-243

Last Modified: 8/10/2007


3.		Phase III Pilot Study of Induction Chemotherapy with VPL (VCR/PRED/L-ASP), Salvage of Induction Failures with High-Dose ARA-C/L-ASP, and Intensification/Maintenance with ARA-C/ADR/L-ASP/PRED/VCR/MTX vs ARA-C/TBI/Allogeneic BMT in Children with Relapsed ALL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 18				NCI				CCG-181P

Last Modified: 5/2/2007


4.		Phase I-II Chemotherapy with Cyclocytidine for Refractory Acute Leukemia, Lymphomas and Solid Tumors in Children

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				under 21				NCI				POG-7516


5.		Phase II Pilot Study of Chemotherapy with DBD/CYC for Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D81-032-301


6.		Phase II Chemotherapy with Cyclocytidine for Primary or Recurrent Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-7437


7.		Phase II Study of Single-Agent Chemotherapy with Cyclocytidine for Disseminated Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				SWOG-7504


8.		Phase II Chemotherapy with Cyclocytidine for Children with Acute Leukemia and Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				under 18				NCI				CCG-051


9.		Phase II Pilot Study of Induction with CYC/AMSA and Maintenance with VP-16/AMSA for Pediatric Acute Leukemia or CML in Blastic Crisis in Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 15								MSKCC-8143


10.		ROAP - Rubidazone/VCR/ARA-C/PRED plus MER-BCG Immunotherapy for Acute Nonlymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Closed				over 50								MDA-DT-7635A

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute